News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Patent News
CRISPR (CRSP), Intellia, Caribou Biosciences And ERS Genomics Announce Appellate Brief Seeking Reversal Of U.S. Patent Board Decision On CRISPR/Cas9 Gene Editing 7/26/2017
Compugen Ltd. (CGEN) Announces Issuance Of U.S. Patent For COM701, Its Lead Immuno-Oncology Product Candidate 7/26/2017
Bristol-Myers Squibb (BMY), Medicines Patent Pool Extend Licence For Atazanavir To 122 Developing Countries 7/26/2017
Compugen Ltd. (CGEN) Announces Issuance Of U.S. Patent For COM701, Its Lead Immuno-Oncology Product Candidate 7/25/2017
Azargen Biotechnologies Granted European Patent For Plant-Made Production Of Recombinant Human Surfactant Protein-B 7/25/2017
Patent For Enhancing Immunotherapy In Cancer Treatment Granted To Galectin (GALT) 7/25/2017
Cellectis (CLLS) Granted Patent For CRISPR Use In T-Cells 7/25/2017
Fluicell Receives A New Patent Acceptance For The BioPen System 7/24/2017
SpinalCyte, LLC Receives New Japanese Patent 7/21/2017
EnteroMedics (ETRM) Announces Receipt Of European Patent Certificate 7/20/2017
CureVac To Receive Patent Claiming The Combination Of mRNA Vaccines With Anti-PD-1 Antibodies 7/20/2017
Propanc Receives Acceptance Of Key Patent Application For Cancer Treatment In China 7/20/2017
Intec Pharma Granted Patent In Hong Kong For Accordion Pill Carbidopa / Levodopa 7/19/2017
Lifetrack Medical Systems Awarded Its Second U.S. Patent, Streamlining Workflow Adaptability And Security Management For Distributed Radiology 7/19/2017
European Patent Issued For Human And Pet Anti-Obesity Vaccine To Braasch Biotech 7/19/2017
BioMarker Strategies Announces Issuance Of Key Patent In Europe Covering The Company’s Pathmap Functional Signaling Profile Technology 7/19/2017
Bio-Path Holdings, Inc. (BPTH) Receives Notice Of Allowance For Key U.S. Composition Of Matter Patent 7/19/2017
ModGene Pharma Announces Issuance Of U.S. Patent For Alzheimer's Disease Prevention 7/19/2017
Kura Oncology Announces Issuance Of U.S. Patent For Lead Product Candidate Tipifarnib In Head And Neck Cancer 7/18/2017
uniQure (QURE) Expands Intellectual Property Portfolio With Newly Issued Patent Providing Broad Protection Of Insect Cell-Based AAV Manufacturing 7/18/2017
Perrigo (PRGO) Announces Settlement Of Generic Version Of Dymista Nasal Spray Patent Litigation 7/17/2017
Perrigo (PRGO) Confirms Patent Challenge For Generic Version Of Soolantra Cream, 1% 7/17/2017
Fortress Biotech (FBIO) Announces Filing Of Provisional Patent Application For Caelum Biosciences' CAEL-101 7/17/2017
Vanessa Research, Inc. Receives EU Patent For Shylicine, A Therapy For A Rare Pediatric Disorder 7/14/2017
Immune Pharma’ Oncology Subsidiary, Cytovia, Inc. (MAXM), Announces The Filing Of A World-Wide Patent Protecting The Use Of Ceplene In Acute Myeloid Leukemia (AML) And Other Hematological Cancers With Mutated NPM1 7/13/2017
Biohaven (BHVN) Receives Notice Of Allowance From U.S. Patent And Trademark Office On Patent Application For Glutamate Modulating Prodrugs 7/13/2017
Eli Lilly (LLY) Reaches Settlement Agreement In U.S. Cialis Patent Litigation 7/12/2017
Strathspey Crown LLC Announces Issuance Of US Patent Of The First Implantable Intraocular Lens (IOL) With A Video Camera And Wireless Transmission Capability 7/12/2017
U.S. Patent Granted To Azargen Biotechnologies For Synthetic Promoter Technology 7/12/2017
Sanovas Awarded U.S. Patent for Treatment of Hypoxic Tumors with Localized Oxygenation 7/11/2017
Rexahn Pharmaceuticals, Inc. (RNN) Receives Notice Of Allowance For A New U.S. Patent Covering The Use Of RX-3117 7/10/2017
NewLink Genetics (NLNK) Receives Notice Of Allowance From USPTO Covering Indoximod Salts And Prodrugs 7/10/2017
OWC Pharmaceutical Research Corp. Takes Further Actions To Protect Its Intellectual Property 7/10/2017
Regeneus (RGS.AX) U.S. Patent Allowed For Sygenus Secretions Technology For Acne 7/10/2017
UK Supreme Court Rules In Eli Lilly (LLY)'s Favor On Alimta Vitamin Regimen Patents 7/7/2017
InDex Pharmaceuticals AB Gets New Patent Granted In Europe 7/6/2017
Mithra Pharmaceuticals Strengthens E4 Patent Position In Australian Market 7/6/2017
GlycoMimetics (GLYC) To Receive European Patent For GMI-1271 7/6/2017
Cytori (CYTX) Receives Key Cell Therapy Patent For Scleroderma 7/6/2017
Opthea Receives Notice Of Allowance For Key Patent Covering OPT-302 In The United States 7/6/2017
VIVUS (VVUS) Announces Settlement With Actavis (ACT) On Qsymia Patent Litigation 7/6/2017
Horizon Discovery Takes Exclusive License For Novel Transposon-Based Gene Editing Technology Platform 7/5/2017
Glytec LLC Receives Five Additional Patent Allowances For Its Diabetes Therapy Management Software 6/30/2017
Sanovas Awarded Seminal Patent For Imaging Stylet For Intubation 6/29/2017
U.S. Patent Office To Confirm Kite Pharma (KITE)’s Seminal Eshhar CAR-T Patent 6/28/2017
Xylogenics Announces Latest Advancements In Patented GX-1 Yeast Technology 6/27/2017
Synthetic Biologics (SYN) Announces Allowance Of Key U.S. Patent Covering SYN-010 Intended For The Novel Treatment Of Irritable Bowel Syndrome With Constipation (IBS-C) 6/27/2017
Oramed (ORMP) Granted Japanese Patent For Combination Insulin And GLP-1 Analog Capsule 6/27/2017
Aralez Announces District Court Decision To Uphold VIMOVO (Naproxen/Esomeprazole Magnesium) Patents 6/27/2017
OWC Pharmaceutical Research Corp. Announces Market Readiness Of Its Cannabinoid-Based Topical Cream For Skin Conditions Starting With Psoriasis 6/27/2017
Horizon Pharma (HZNP) Announces District Court Decision To Uphold VIMOVO (Naproxen/Esomeprazole Magnesium) Patents 6/27/2017
Opiant Pharma Announces FDA Orange Book Listing For New NARCAN Nasal Spray Patent 6/27/2017
TrovaGene (TROV) Announces Expansion Of Key Claims For Its NPM1 Patent Portfolio For Acute Myeloid Leukemia 6/26/2017
Bone Therapeutics: Receives Intent To Grant Notice From European Patent Office For Allogeneic Bone Cell Therapy Platform 6/26/2017
Axim Biotech Files Patent On Controlled Release Chewing Gum To Provide Opioid Addiction Treatment 6/23/2017
Patent For Reducing Inflammatory Response Granted To Galectin (GALT) 6/21/2017
Zyga Tech Receives New Patent Allowances For SImmetry Sacroiliac Joint Fusion System 6/21/2017
Association of University Technology Managers Release: New Report: Licensing Of Academic Patents Has Contributed Up To $1.3 Trillion To U.S. Economy 6/21/2017
Cynata Receives Notice Of Allowance From U.S. Patent And Trademark Office For Cymerus Patent Application 6/20/2017
Citius Pharma Announces US Patent Office Publication Of Enhanced Stability Patent Application Covering Mino-Lok 6/20/2017
Kibow Biotech, Inc. (Buzz Of Bio Winner, 2014) Receives US Patent For Gout/Hyperuricemia Product Formulation Based On Modulation Of The Gut Microbiome With Probiotics And Prebiotics 6/20/2017
Cynata Files New Patent Application For Cymerus Stem Cell Technology In Oncology 6/20/2017
CRISPR (CRSP) Announces Patent For CRISPR/Cas Genome Editing In China 6/19/2017
Intellia Announces Patent For CRISPR/Cas Genome Editing In China 6/19/2017
Oxford Immunotec (OXFD) Announces Favorable Claim Construction Ruling In Patent Infringement Litigation 6/16/2017
Intensity Therapeutics, Inc. Issued New Patents For Technology Platform 6/15/2017
Fluicell Receives Green Light With A New BioPen Patent In The U.S.A. 6/14/2017
MilliporeSigma Awarded Its First CRISPR Patent By Australian Patent Office 6/14/2017
Following The US, Cellect (APOP) Receives Russian Patent Covering Any Device And Method Using Cellect's Flagship Technology - The Apograft 6/14/2017
NeuroMetrix (NURO) Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology 6/13/2017
RegeneRx Biopharmaceuticals, Inc. (RGRX) Collaborators Receive Notice Of Allowance Of U.S. Patent For The Treatment Of Peripheral Neuropathy 6/13/2017
European Patent Office Confirms Grant Of New ICE COLD-PCR Patent Exclusively Licensed To Transgenomic, Inc. (TBIO) 6/13/2017
Taxus Cardium (CRXM) Release: Excellagen Receives USPTO Notice Of Allowance For A New Patent Application Covering Blood Platelet Activation & Endogeneous Growth Factor Release For Wound Repair And Tissue Regeneration 6/13/2017
Leonhardt Adds HIF-1 Alpha To Estate Of Bioelectric Controlled Release Regenerative Proteins 6/13/2017
Nobilis Receives A Notice Of Allowance For A Patent Covering Treatment Of Psychiatric Disorders With Noble Gases 6/13/2017
Alnylam (ALNY) Significantly Expands Patent Portfolio With New Allowances From United States Patent And Trademark Office 6/12/2017
Cellect Receives Notice Of Allowance From The U.S. Patent & Trademark Office 6/12/2017
CollPlant Files Patent For 3D Bio-Printing Of Organs And Tissues 6/12/2017
Creative Medical Technology Develops Platform Aimed At Augmenting All Mesenchymal Stem Cell Therapies For Lower Back Pain 6/8/2017
Cell Design Labs Announces Issuance Of Broad Patent For Chimeric Notch (Synnotch) Receptor To Treat Cancer And Other Diseases 6/7/2017
Autoimmune Disease Patent Granted To Galectin (GALT) 6/6/2017
M Pharmaceuticals Receives USPTO Trademark Protection For Extrinsa For The Treatment Of Female Sexual Dysfunction 6/6/2017
Zenith Technologies Announces Issuance Of Patent For ZEN-3694 And Presentation Details At BIO International Convention 6/5/2017
Egalet Announces Issuance Of New U.S. Patent For Guardian Technology 6/5/2017
Akebia (AKBA) Prevails In Two Additional European Patent Disputes 6/5/2017
European Patent Office Maintains FibroGen (FGEN) Patent Relating To Hypoxia-Inducible Factor (HIF) Prolyl Hydroxylase Inhibitor Technology 6/5/2017
Blue Spark Technologies , Inventor Of The Temptraq Wearable, Bluetooth Temperature Monitor, Awarded Patent 6/5/2017
Blue Spark Technologies , Inventor Of The TempTraq Wearable, Bluetooth Temperature Monitor, Awarded Patent 6/2/2017
Retrophin (RTRX) Announces Expansion Of Intellectual Property Estate For Sparsentan With Newly Issued Patents In The United States And Europe 6/1/2017
ProLynx Issued US Patent For Cleavable Linker Technology On Hydrogels 5/31/2017
Elite Pharma (ELI) Granted New Patent For Abuse Deterrent Technology 5/31/2017
Microbot Medical Inc. Announces Issuance Of A Canadian Patent Covering A Self-Cleaning Shunt 5/31/2017
Forward Pharma (FWP) Appeals The Initial Decision In The U.S. Patent Interference To The Federal Circuit 5/31/2017
Vedanta Biosciences Granted U.S. Patent Broadly Covering Methods Of Treatment With Therapeutics Based On Bacterial Spore Fractions Of Microbiota Obtained From Human Donors 5/30/2017
Sierra Oncology Granted US. And EU Patents For Chk1 inhibitor SRA737 5/30/2017
NuGEN Announces Issuance Of U.S. Patent For Its Single Primer Target Enrichment Technology (SPET) For Next Generation Sequencing Applications 5/30/2017
Celyad Obtains Additional US Patent For Cancer Treatment Based On TCR-Deficient Allogeneic CAR-T Cells 5/30/2017
Neurana Pharma Receives Notice Of Allowance Of Patents For Tolperisone, A Novel Skeletal Muscle Relaxant 5/26/2017
SurGenTec’s GRAFTGUN Receives Key Patent 5/26/2017
Creative Medical Technology Files Patent On AmnioStem Mediated Immune Reprogramming For Stroke 5/25/2017
Diba Industries, Inc. Announces Issuance Of U.S. Patent For Multistage Syringe Assembly 5/25/2017
Ammonett Pharma Receives Notice Of Allowance Of U.S. Patent For Oratrope Related To Detecting And Treating Growth Hormone Deficiency 5/25/2017
Intec Pharma Granted U.S. Patent For Accordion Pill Comprising Levodopa For Improved Treatment Of Parkinson's Diseases Symptoms 5/24/2017
Great Basin Scientific Issued Second U.S. Patent For PCR Amplification Suppressor 5/24/2017
Regeneus (RGS.AX) Japanese Patent Office To Grant Key Patent For Progenza 5/24/2017
GB Sciences Files Patent Application For Chronic Pain And Heart Therapies 5/23/2017
DSM Sinochem Pharma Wins Indian Patent Infringement Case Against Sinopharm Weiqida Pharmaceutical 5/23/2017
Resverlogix (RVX.TO) Release: Recent Publication And Patent Application Referencing Apabetalone Support Its Continued Development And Success 5/23/2017
Helius Medical Technologies Receives First Of Two Human Performance Patents 5/23/2017
Origenis Announces Patent Grants For Lead Small Molecule LRRK2 Inhibitors For Treatment Of Neurodegenerative And Inflammatory Diseases 5/23/2017
Herantis Pharma Granted A U.S. Patent On Therapeutic Use Of MANF 5/23/2017
Biocept (BIOC) Awarded U.S. Patent With Broad Claims For Antibody Capture Of Targets Of Interest On Any Solid Surface Including Ctcs And Other Materials Shed By Solid Tumors Into Blood 5/22/2017
Avenue Therapeutics Receives Notice Of Allowance For A New Patent Application Covering Methods Of Administration For Intravenous Tramadol 5/19/2017
Why This Humira Patent Loss Might Not Be What You Think 5/18/2017
CURE Pharma Announces Crosslink Patent For Covering Company’s Proprietary Curefilm Drug Delivery Technology 5/18/2017
NEMUS Bioscience Reports Prodrug Of Tetrahydrocannabinol (THC) Issued Patent Coverage In Canada And Hong Kong 5/18/2017
Visionsense Files For An Inter Partes Review (IPR) Against Novadaq Technologies, Inc.'s U.S. Patent 8,892,190 5/17/2017
Statement By ResMed (RMD) On Plans To Renew Its Patent Infringement Case Against Fisher & Paykel 5/17/2017
Coherus Prevails In ‘135 IPR Decision 5/17/2017
Axis Biotec Innovative Wound Dressing’s IP Issued In Germany 5/17/2017
Vedanta Biosciences Granted Three U.S. Patents Broadly Covering Pharmaceutical Compositions And Methods Of Use For Therapeutics Based On Immune-Modulating Bacterial Consortia 5/16/2017
Synaffix Secures End-to-End Patent Protection Of Its ADC Technology Platform As Its HydraSpace Patent Grants In The United States 5/16/2017
Albireo (ALBO) Announces Two New U.S. Patents Allowed For A4250 With Term Into 2031 5/16/2017
Struggling XBiotech (XBIT) Quietly Discloses Exec Resignation 5/15/2017
Nuvo Pharma Announces District Court Decision To Uphold U.S. Pennsaid 2% Patent 5/15/2017
Glactone Granted Patent For STAT3 Inhibitors 5/15/2017
Progenra, Inc. Receives Second Immune Oncology Patent 5/11/2017
Avita Medical Initiates Legal Proceedings To Cancel Renovacare Patent 5/11/2017
Calyxt Patent Encompassing Broad Uses Of Plant Gene Editing Technologies Maintained By USPTO 5/11/2017
Cellectis (CLLS) Patent Encompassing Broad Uses Of Gene Editing Technologies Maintained By USPTO 5/11/2017
InMed Files Provisional Patent Application For Ophthalmic Drug Delivery 5/11/2017
Caribou Biosciences Announces Grant Of A Key CRISPR-Cas9 Genome Editing Patent In Europe 5/10/2017
Onxeo Announces Allowance Of U.S. Patent For Livatag In Hepatocellular Carcinoma 5/10/2017
NEMUS Bioscience Reports Prodrug Of Tetrahydrocannabinol (THC) Receives Second Patent Issued In The United States Related To Proprietary Delivery Mechanisms For Treatment Of Glaucoma 5/10/2017
Oramed (ORMP) Granted Canadian Patent For GLP-1 Analog Capsule 5/9/2017
Soligenix (SNGX) Receives Japanese Patent For ThermoVax Vaccine Heat Stabilization Platform Technology 5/9/2017
Pulmatrix (PULM) Receives Key US. Patent For Its Inhaled Drug For COPD 5/9/2017
Visualant Granted Biological Tissue Patent 5/9/2017
AgriLabs, Ltd. Release: Broad Patent Granted for ENABL Adjuvant Technology 5/9/2017
AVEO Oncology (AVEO) Announces Receipt Of USPTO Notice Of Allowance Related To AV-353 5/8/2017
Ocugen, Inc. Expands Global Patent Portfolio For OCU200 5/8/2017
Savara Announces Issuance Of U.S. Composition Of Matter Patent Covering AeroVanc 5/8/2017
Almac Discovery Announce Key Wee-1 Kinase Patent Approval 5/8/2017
Key Patent Issues Covering Protagonist (PTGX)' Oral Peptide IL-23 Receptor Antagonists, Including The Development Candidate PTG-200 5/5/2017
Cleveland HeartLab LLC Adds Two Additional Patents To Its Extensive Intellectual Property Position For The Myeloperoxidase (MPO) Test, A Key Predictor Of Major Cardiac Events 5/4/2017
Stainwei Granted U.S. Patent For Anti-VEGF Monoclonal Antibody And Its Anti-PD-1 Mab Demonstrating Prolonged Anti-Tumor Activity In Pre-Clinical Studies 5/3/2017
Ritter Pharma Announces Issuance Of New Patents For Its Lactose Intolerance Treatment, RP-G28, And Provides An Update On Its Path Forward Into Phase III 5/3/2017
bluebird bio (BLUE) Licenses Lentiviral Vector Patent Rights For Development And Commercialization Of Cell Therapies 5/2/2017
bluebird bio (BLUE) Enters Lentiviral Vector Patent License Agreement With GlaxoSmithKline (GSK) For Commercialization Of Gene Therapies 5/2/2017
Tonix Pharma (TNXP) Announces Issuance Of U.S. Patent For Tnx-102 Sl Composition And Formulation: Designed For Transmucosal Absorption And Bedtime Daily Use 5/2/2017
SteadyMed (STDY) Receives USPTO Notice Of Allowance For Patent Related To Key Patchpump Technology 5/2/2017
Celyad Grants To Novartis AG (NVS) A Non-Exclusive License For Its Allogeneic TCR-Deficient CAR-T Cells Patents 5/2/2017
Caribou Biosciences Announces Grant Of A Key CRISPR-Cas9 Patent In The U.S. 5/2/2017
ReForm Biologics Announces Issuance Of U.S. Patent For New Excipient To Improve Antibody-Based Therapeutics 5/1/2017
CEL-SCI (CVM) Receives Intent To Grant Notice For New Multikine Patent From The European Patent Office 4/28/2017
Providence Medical Technology Announces Issuance Of Four Additional U.S. Patents 4/27/2017
SpinalCyte, LLC Receives New Australian Patent 4/27/2017
ArQule (ARQL) Announces Issuance Of U.S. Patent Covering Composition Of Matter Of Proprietary Reversible BTK Inhibitor, ARQ 531 4/26/2017
Out Of Silicon Valley, A Billion-Dollar Orthodontics Business Built With Plastic And Patents 4/26/2017
Intellia And CRISPR (CRSP) Announce U.S. Patent Covering CRISPR/Cas9 Ribonucleoprotein Complexes 4/26/2017
Aclaris (ACRS) Announces Notice Of Allowance For A U.S. Patent Application Covering Lead Candidate A-101 Topical Solution 4/26/2017
Asuragen, Inc. Strengthens Repetitive Sequence And Short Structural Variant Intellectual Property Portfolio 4/25/2017
United States Patent Issued To Replicel Life Sciences For Its Novel Dermal Injection Technologies 4/25/2017
MPEG LA Invites CRISPR-Cas9 Patents To Be Pooled In A One-Stop License 4/25/2017
Galectin (GALT) Receives Notice Of Japanese Decision To Grant A Composition Of Matter Patent For GR-MD-02 4/25/2017
Cellectar Biosciences  (CLRB) Receives Additional U.S. Patents For PDC Optical Agents In The Detection Of Multiple Cancers 4/25/2017
Coherus Completes Patent Dance Exchange With Amgen (AMGN) For Neulasta Biosimilar 4/25/2017
Mati Therapeutics Hits Major Milestone With 100 Patents 4/25/2017
Benevir Biopharm Granted Patent Protecting Lead Oncolytic Immunotherapy Stealth-1H And Other Platform Assets 4/25/2017
PDL BioPharma (PDLI) Announces Settlement Of Keytruda Patent Infringement Lawsuit With Merck & Co. (MRK) 4/24/2017
Acasti Pharma Granted Additional Composition & Use Patents In Taiwan And Australia; Safeguards Valuable Market Expansion Opportunities 4/24/2017
Mount Tam Biotechnologies Announces That The European Patent Office Has Allowed A Key Patent For Lead Compound TAM-01 4/24/2017
Oramed (ORMP) Granted European Patent For Combination Oral Insulin And GLP-1 Analog Capsule 4/20/2017
BioRestorative Receives Notice Of Acceptance For Key Metabolic Patent In Australia 4/20/2017
Argentum And Allergan (AGN) Settle Patent Dispute Over RESTASIS 4/19/2017
Egaceutical Corporation Demonstrates Human Age Reversal, Patent Is Pending 4/19/2017
Pluristem Therapeutics (PSTI) Reaches Milestone Of 100 Granted Patents, Including Coverage Of Leading Indications In Major Markets 4/19/2017
Spherix (SPEX) Announces Economic Interest Acquired In New Patent Portfolio 4/19/2017
EyeLock Receives Patent For Mobility Identity Platforms 4/19/2017
Kura Oncology Granted U.S. Patent For Clinical-Stage ERK Inhibitor, KO-947 4/19/2017
Spectro Scientific Wins Patent For Extending Lasernet Fines Particle Analysis Technology With Ferrous Particle Measurement Capability 4/19/2017
Biocept (BIOC) Awarded Additional Patent In Japan Expanding Intellectual Property Estate To 19 Issued Patents Protecting Its Target Selector Liquid Biopsy Platform 4/18/2017
Cellectar Biosciences  (CLRB) Receives Japanese Patent For CLR 131 And CLR 125 For The Treatment Of Cancer Stem Cells 4/18/2017
Santalis Announces Issuance Of An Australian Patent Covering The Use Of Sandalwood Oil To Treat Cancers 4/18/2017
RedHill Biopharma (RDHL) Receives Notice Of Allowance For Two Additional U.S. Patents Covering BEKINDA 4/18/2017
Repros Therapeutics (RPRX) Announces The Issuance Of New U.S. Patent Relating To Treatment Using Off Drug Intervals For Certain Uterine Conditions 4/17/2017
Helius Medical Technologies Receives Two Medical Method Patents 4/17/2017
LegoChem Biosciences Receives U.S. Patent For Its Own Proprietary ADC Platform Technology ConjuAll 4/17/2017
Incysus Granted European Patent Covering Its Drug Resistant Immunotherapy (DRI) Technology 4/13/2017
BioMarin (BMRN) Announces Kuvan (sapropterin dihydrochloride) Patent Challenge Settlement 4/13/2017
Innovus Pharma Receives Patent For Its Sensum+ Product In Morocco 4/12/2017
Synergy Pharma (SGYP) Announces Issuance Of Three New Patents Expected To Extend TRULANCE (Plecanatide) Patent Protection Until 2032 4/12/2017
Intellia Announces European Patent Office’s Decision to Grant CRISPR/Cas9 Genome Editing Technology Patent 4/11/2017
Hi-Tech Pharmacal (HITK) Wins Almost $1 Million In Legal Fees From Thermolife And Stanford University After Winning Major Patent Case 4/10/2017
Intellipharmaceutics (IPCI) Announces Patent Litigation By Purdue Pharma L.P. Against Its Rexista Abuse-Deterrent Extended-Release Oxycodone 4/10/2017
KFx Medical Announces Another And Third License Of Its Knotless Double Row Patents 4/7/2017
IBM (IBM) Patents Machine Learning Models For Drug Discovery 4/7/2017
Jazz Pharma (JAZZ) Reaches Settlement With Hikma (HIK.L) Related To Xyrem Patent Litigation 4/6/2017
APR Applied Pharma Research S.A. Wants To Make The Difference For PKU People Thanks To An Innovative And Patented Technology 4/6/2017
SpinalCyte, LLC Receives New European Patent 4/6/2017



//-->